Nadda hails ICMR-NIMR on 50 years of malaria research
Synopsis
Key Takeaways
Fifty years of fighting one of humanity's oldest killers — and Union Health Minister J. P. Nadda marked the milestone on Tuesday, 17 November 2026, with a warm tribute to ICMR-NIMR, India's premier malaria research institution, as it completes half a century of work in vector biology, drug resistance, and disease control.
Nadda posted in Hindi: '1977 में स्थापना के बाद से ICMR-NIMR ने 50 वर्षों की गौरवशाली यात्रा में अनुसंधान, नवाचार और मलेरिया उन्मूलन के क्षेत्र में महत्वपूर्ण योगदान दिया है' — 'Since its establishment in 1977, ICMR-NIMR has made significant contributions to research, innovation, and malaria elimination over 50 glorious years.' He added that the NIMR family had built 'an inspiring legacy of dedication, knowledge, and public service,' and extended 'heartfelt congratulations and best wishes' to the entire institution.
From the 1977 policy reset to a golden jubilee
ICMR-NIMR was not born in a vacuum. Its founding in 1977 coincided directly with India's Modified Plan of Operation — a strategic reorientation of the national malaria programme after a sharp disease resurgence threatened to undo the gains of the earlier National Malaria Eradication Programme launched in 1958. Policymakers of that era recognised that operational control alone was not enough; sustained scientific research was essential. NIMR was the institutional answer to that reckoning.
Over five decades, the institute has built expertise in malaria vector biology, parasite drug resistance, and field-level surveillance tools — underpinning the work of frontline programmes run through the National Vector Borne Disease Control Programme. That research-to-programme pipeline is exactly what India needs as it chases a demanding target: malaria elimination by 2030, aligned with WHO global benchmarks.
Why the 2030 deadline makes this jubilee consequential
India's 2030 malaria elimination goal is ambitious — and the clock is running. With roughly four years left, the pressure on ICMR-NIMR to deliver next-generation surveillance methods, drug-resistance data, and vector-control innovations is higher than at any point in the institution's history. The jubilee is a moment of pride, but it also sharpens the stakes.
Nadda, who oversees both health policy and the broader pharmaceutical ecosystem as Minister of Chemicals and Fertilizers, framing this tribute publicly signals that the Centre views NIMR's scientific mandate as central — not peripheral — to the national health agenda. Watch for new NIMR-led field trials or updated surveillance protocols in the months ahead as India approaches critical WHO assessment windows.